REMS Abuse Website: Has It Changed The Behavior Of Innovators?

 
• By Michael Cipriano

Updated numbers from the US FDA's REMS abuse website show that Celgene has received two additional safety determination letters, raising question's about whether the public list has changed the practices of brand companies hindering generic company access to samples.

The Shame
Has FDA been effectively shaming pharma companies? • Source: Grey World

More from Generics

More from Biosimilars & Generics